Novartis India shares rallied 51% over three days following the acquisition of the Minipress and Minipres brand portfolio from Pfizer for ₹1,250 crore. This strategic move aims to boost the company’s cardiovascular presence under its new ownership, though investors should note the rapid stock price surge and the brand's moderate historical growth rates.
Novartis India reached a 52-week high of ₹2,474.90 on Thursday as investors reacted to the company’s acquisition of the 'Minipress' and 'Minipres' brand trademarks and intellectual property from Pfizer Inc. and Pfizer Products Inc. The stock price has surged 51% over the last three trading sessions following the announcement.
The ₹1,250 crore deal gives Novartis the rights to the Minipress XL drug, which is used for treating hypertension and symptoms of benign prostatic hyperplasia. Pfizer has officially discontinued the marketing and distribution of these products in India as of September 7, 2026, marking a complete transition of the franchise to Novartis.
This acquisition is a significant development following the recent change in ownership at Novartis India. In July 2026, the private equity firm ChrysCapital completed a 70.68% majority stake takeover of the company. The deal appears to be part of the new management's efforts to strengthen the company’s footprint in the cardiovascular and urology therapeutic areas.
From a financial perspective, the Minipress XL brand has established a steady presence, generating approximately ₹228.6 crore in revenue as of July 2026. However, the brand has grown at a compound annual rate of 6.3% over the past four years. This is slower than the 9% growth rate seen in the broader therapy category, suggesting the brand is in a mature phase of its life cycle.
Investors should be aware of a few factors regarding this price movement. The 51% rally in share price in such a short period often brings increased volatility, as market participants digest the news. Furthermore, the long-term success of this acquisition will depend on how effectively the company integrates the brand under the new ownership structure and whether it can reverse the trend of slower growth compared to the wider market. Going forward, market observers will likely monitor how this brand contributes to the company's revenue and whether management can leverage the portfolio to improve overall profitability.